Charlotte Loflin
Gerontology · Round Rock, TXNPI 1255885448
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,727 of the $9,189 with a category attached, or 73.2%. 29 manufacturers reported payments, led by Biodelivery Sciences International, Inc. at 27.9% of the total. Reporting peaked in 2021 at $3,534 and has fallen 93.9% since, to $217 in 2025. Among gerontology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 221 payments — averaging $41.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biodelivery Sciences International, Inc.$3K
- Abbott$1K
- Boston Scientific$1K
- AbbVie$827
- Collegium Pharmaceutical, Inc.$601
- Relievant Medsystems, Inc.$514
- plus $2K from 23 others
What the payments were for
- Consulting fees$1,95021%
- Speaking & faculty fees$5136%
- Food & beverage$6,72773%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biodelivery Sciences International, Inc. | 15 | $2,560 |
| Abbott | 37 | $1,316 |
| Boston Scientific | 26 | $1,131 |
| AbbVie(2 entities) | 34 | $827 |
| Collegium Pharmaceutical, Inc. | 27 | $601 |
| Relievant Medsystems, Inc. | 5 | $514 |
| Nalu Medical, Inc. | 3 | $350 |
| GRT US Holding, Inc. | 9 | $267 |
| Pfizer | 12 | $219 |
| Spinal Simplicity, LLC | 2 | $196 |
| Medtronic | 5 | $155 |
| Globus Medical | 1 | $150 |
| Scilex Pharmaceuticals Inc. | 8 | $142 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $117 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $101 |
| Amgen(2 entities) | 4 | $93 |
| Averitas Pharma Inc. | 4 | $91 |
| USWM, LLC | 4 | $60 |
| IBSA Pharma Inc. | 3 | $49 |
| Merz Pharmaceuticals, LLC | 1 | $40 |
| Foundation Fusion Solutions, LLC | 1 | $37 |
| Hikma Pharmaceuticals USA | 2 | $33 |
| Redhill Biopharma Inc. | 2 | $28 |
| Pacira Pharmaceuticals Incorporated | 1 | $23 |
| Johnson & Johnson | 1 | $22 |
| Lilly USA, LLC | 1 | $22 |
| Bioventus LLC | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Ipsen Biopharmaceuticals, Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BELBUCA$2,463
- Intracept$1,174
- Symproic$513
- GENERAL PAIN MANAGEMENT$464
- PROCLAIM$407
- Nalu Neurostimulation System$350
- BOTOX$240
- HA MINUTEMAN G3-R$174
- Senza$150
- Proclaim IPG$143
How this compares
$9,189 in reported general payments places this provider in the 95th percentile of 653 gerontology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 59 | $49,078 |
| Buprenorphine | 31 | $10,193 |
| Gabapentin | 277 | $4,909 |
| Celecoxib | 68 | $2,977 |
| Tizanidine Hcl | 195 | $2,656 |
| Buprenorphine Hcl | 77 | $2,517 |
| Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine | 19 | $2,254 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 22 | $2,249 |
| Methocarbamol | 65 | $1,714 |
| Tramadol Hcl ErTramadol Hcl | 22 | $1,499 |
| Naloxone Hcl | 16 | $1,249 |
| Pregabalin | 94 | $1,110 |
| Duloxetine Hcl | 48 | $993 |
| Lidocaine | 13 | $913 |
| Cyclobenzaprine Hcl | 95 | $876 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca | $601 | $49,07859 claims |
| Hikma Pharmaceuticals USABuprenorphine, Buprenorphine Hcl, Buprenorphine-Naloxone | $33 | $14,959130 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 653 gerontology providers in Texas.
Other gerontology in Round Rock
- Martha MenefeeRound Rock$12K
- Christina BomanRound Rock$5K
- Kimberly WelchCoppell$113K
- Tiffany KesslerDallas$84K
- Jennifer WestFort Worth$67K
- Bailey EstesAbilene$34K
- Scott ZelaHouston$28K
- Marissa Marti-SmithDallas$27K
- Andrew BargerAustin$22K
- Meagan ChavarriaHouston$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.